Bioequivalence requirements for generic products
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 62 (1-2) , 41-55
- https://doi.org/10.1016/0163-7258(94)90004-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Enantioselective versus non‐enantioselective assays in comparative bioavailability studies with racemic drugsBiopharmaceutics & Drug Disposition, 1992
- Enantioselective versus non‐enantioselective assays in comparative bioavailability studies with racemic drugsBiopharmaceutics & Drug Disposition, 1992
- Pharmacodynamics as a tool to assess the bioequivalence of nonystemically available drugs: Size of the sample requiredBiopharmaceutics & Drug Disposition, 1992
- Genetic Aspects of Drug Disposition and TherapeuticsThe Journal of Clinical Pharmacology, 1992
- Interactions with oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1990
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- Stereoselective drug disposition: potential for misinterpretation of drug disposition data.British Journal of Clinical Pharmacology, 1988
- Application of a Stereospecific High-Performance Liquid Chromatography Assay to a Pharmacokinetic Study of Etodolac Enantiomers in HumansJournal of Pharmaceutical Sciences, 1988
- Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overviewClinical Pharmacology & Therapeutics, 1986
- Pharmacokinetic Determinants in the Design and Evaluation of Sustained-Release Dosage FormsPharmaceutical Research, 1984